Commonwealth Numbered Regulations

NATIONAL HEALTH (PHARMACEUTICAL BENEFITS) AMENDMENT REGULATIONS 2010 (NO.5) (SLI NO 296 OF 2010) - REG 8

         (1)   This regulation applies to a listed brand of a pharmaceutical item (the relevant brand ) if:

                 (a)     the price disclosure requirements first apply under section 99ADD of the Act for the relevant brand on a day (the relevant day ); and

                (b)     both on and before the relevant day, the price disclosure requirements apply for any other listed brand of any pharmaceutical item having the same drug and manner of administration (the other brand ) as the relevant brand; and

                 (c)     the other brand is in the third transitional cycle.

         (2)   T he first reporting period for the relevant brand:

                 (a)     begins on the relevant day; and

                (b)     ends at the end the first of the following days to occur after the relevant day:

                          (i)     31 March 2011;

                         (ii)     30 September 2011;

                         (iii)     31 January 2012.